Functional Neuroimaging and Genetic Vulnerability to Suicidal Behavior
Not Applicable
Terminated
- Conditions
- Suicidal Behavior
- Interventions
- Device: Magnetic resonance imaging (MRI)
- Registration Number
- NCT02960191
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
The main objective is to highlight, by functional imaging (MRI) dysfunctional brain regions associated with vulnerability to suicidal behavior.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Male
- Target Recruitment
- 95
Inclusion Criteria
- right-handed
- arm suicidal : Personal history of unipolar depressive disorder or bipolar disorder and having realized in his life at least one suicide attempt
- arm emotional Witnesses : Personal history of unipolar depressive disorder or bipolar disorder and have never done in his life attempted suicide
- arm healthy Witnesses : any current or past personal history of psychiatric disorders of Axis I and have never done in his life attempted suicide
Exclusion Criteria
- Cons-indications to the use of MRI
- Existence of a past history of head trauma with loss of consciousness or neurological brain disorder or secondary neurological suffering suicidal gesture.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description emotional witness Magnetic resonance imaging (MRI) subject having had a personal history of unipolar or bipolar depressive disorder and who have never done in his life attempted suicide patient suicide Magnetic resonance imaging (MRI) subject having had a personal history of unipolar or bipolar depressive disorder and having realized in his life at least one suicide attempt healthy volunteers Magnetic resonance imaging (MRI) subject with no current or past personal history of psychiatric disorders and about never having carried out suicide attempt
- Primary Outcome Measures
Name Time Method MRI variations at day 0 activation of specific brain areas during the procurement of a test decision
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital of Montpellier
🇫🇷Montpellier, France